Donald J. Griffith Sonnet Bio Therapeutics Holdings, Inc. (SONN) insider trading activity

Donald J. Griffith is Chief Financial Officer of Sonnet BioTherapeutics Holdings, Inc.. Currently has a direct ownership of 10,375 shares of SONN, which is worth approximately $46,998. The most recent transaction as insider was on Jul 11, 2025, when has been sold 10,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.4K

2666.67% 3M change

2666.67% 12M change

Total Value Held $46,998

Donald J. Griffith Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 11 2025	BUY Grant, award, or other acquisition	-	10,000 Added 49.08%	10,375 Common Stock
Dec 11 2023	BUY Grant, award, or other acquisition	-	317 Added 45.81%	375 Common Stock
Feb 06 2023	SELL Payment of exercise price or tax liability	$516 $1.04 p/Share	497 Reduced 4.6%	10,301 Common Stock
Dec 09 2022	BUY Grant, award, or other acquisition	-	3,214 Added 22.94%	10,798 Common Stock
Apr 08 2022	SELL Payment of exercise price or tax liability	$1,668 $0.37 p/Share	4,507 Reduced 4.07%	106,186 Common Stock
Dec 15 2021	BUY Grant, award, or other acquisition	-	15,000 Added 11.93%	110,693 Common Stock
May 25 2021	SELL Payment of exercise price or tax liability	$6,395 $1.51 p/Share	4,235 Reduced 4.24%	95,693 Common Stock

DJG

Donald J. Griffith

Chief Financial Officer

Princeton,, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SONN shares.

Notify only if

Value

Insider Trading

Get notified when an Sonnet Bio Therapeutics Holdings, Inc. insider buys or sells SONN shares.

Notify only if

Operation

Value

Type

News

Receive news related to Sonnet BioTherapeutics Holdings, Inc.

Track Activities on SONN

Account